These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 20155818

  • 1. Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis.
    Xiao Y, Xu J, Wang S, Mao C, Jin M, Ning G, Xu J, Zhang Y.
    Glia; 2010 Jun; 58(8):932-42. PubMed ID: 20155818
    [Abstract] [Full Text] [Related]

  • 2. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN, Yang CL, Du T, Liu A, Wang AR, Sun WJ, Li X, Li JX, Yan CZ, Liu QJ.
    J Neuroinflammation; 2021 Jun 28; 18(1):145. PubMed ID: 34183017
    [Abstract] [Full Text] [Related]

  • 3. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis.
    Weinger JG, Brosnan CF, Loudig O, Goldberg MF, Macian F, Arnett HA, Prieto AL, Tsiperson V, Shafit-Zagardo B.
    J Neuroinflammation; 2011 May 15; 8():49. PubMed ID: 21569627
    [Abstract] [Full Text] [Related]

  • 4. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV.
    J Neuroinflammation; 2019 Mar 20; 16(1):64. PubMed ID: 30894198
    [Abstract] [Full Text] [Related]

  • 5. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A, Sahu SK, Wu Y, Zaheer A, Haas J, Lee K, Yang B.
    Brain Res; 2007 May 04; 1144():239-47. PubMed ID: 17316572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E, Chanamara S, Pleasure D, Soulika AM.
    J Neuroinflammation; 2012 Jan 16; 9():7. PubMed ID: 22248039
    [Abstract] [Full Text] [Related]

  • 12. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M, Sawitzky M, Fontana A, Suter T.
    Glia; 2010 Apr 16; 58(5):559-71. PubMed ID: 19941340
    [Abstract] [Full Text] [Related]

  • 13. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
    Guo MF, Meng J, Li YH, Yu JZ, Liu CY, Feng L, Yang WF, Li JL, Feng QJ, Xiao BG, Ma CG.
    J Neurol Sci; 2014 Aug 15; 343(1-2):69-75. PubMed ID: 24952673
    [Abstract] [Full Text] [Related]

  • 14. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Juedes AE, Hjelmström P, Bergman CM, Neild AL, Ruddle NH.
    J Immunol; 2000 Jan 01; 164(1):419-26. PubMed ID: 10605038
    [Abstract] [Full Text] [Related]

  • 15. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T.
    J Immunol; 1995 Jan 15; 154(2):944-53. PubMed ID: 7814894
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.
    Brain; 2012 May 15; 135(Pt 5):1586-605. PubMed ID: 22447120
    [Abstract] [Full Text] [Related]

  • 18. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination.
    Defaux A, Zurich MG, Braissant O, Honegger P, Monnet-Tschudi F.
    J Neuroinflammation; 2009 May 07; 6():15. PubMed ID: 19422681
    [Abstract] [Full Text] [Related]

  • 19. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
    Dos Santos AC, Roffê E, Arantes RM, Juliano L, Pesquero JL, Pesquero JB, Bader M, Teixeira MM, Carvalho-Tavares J.
    J Neuroinflammation; 2008 Nov 05; 5():49. PubMed ID: 18986535
    [Abstract] [Full Text] [Related]

  • 20. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW.
    Mol Neurobiol; 2018 Apr 05; 55(4):3007-3020. PubMed ID: 28456941
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.